MARKET

FBIO

FBIO

Fortress Biotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.840
+0.040
+1.43%
Closed 16:00 07/08 EDT
OPEN
2.800
PREV CLOSE
2.800
HIGH
2.860
LOW
2.730
VOLUME
420.18K
TURNOVER
--
52 WEEK HIGH
3.200
52 WEEK LOW
1.040
MARKET CAP
234.23M
P/E (TTM)
-3.0779
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average FBIO stock price target is 9.30 with a high estimate of 19.00 and a low estimate of 4.500.

EPS

FBIO News

More
How R&D Expenses Can Help You Pick Outperforming Stocks
Seeking Alpha - Article · 6d ago
Fortress Biotech Added to Russell 3000® Index
GlobeNewswire · 06/29 13:30
Fortress Biotech Added To Russell 3000 Index
Benzinga · 06/29 12:37
Fortress Biotech to Present at the Raymond James Human Health Innovation Conference
GlobeNewswire · 06/15 13:30
Mustang Bio Announces Offering Of 10.769M Shares At $3.25 Per Share
Benzinga · 06/11 13:03
Fortress Biotech Announces Publication of Study on Estimated Birth Prevalence of Menkes Disease in Molecular Genetics and Metabolism Reports
GlobeNewswire · 06/11 13:00
Fortress Biotech Announces Publication Of Study On Estimated Birth Prevalence Of Menkes Disease In Molecular Genetics And Metabolism Reports
Benzinga · 06/11 12:08
Here is What Hedge Funds Think About Fortress Biotech Inc (FBIO)
In this article we will check out the progression of hedge fund sentiment towards Fortress Biotech Inc (NASDAQ:FBIO) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a comp
Insider Monkey · 06/10 20:18

Industry

Pharmaceuticals
+0.25%
Pharmaceuticals & Medical Research
+0.50%

Hot Stocks

Symbol
Price
%Change

About FBIO

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
More

Webull offers kinds of Fortress Biotech Inc stock information, including NASDAQ:FBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FBIO stock methods without spending real money on the virtual paper trading platform.